• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Alex, Argentina

    Alex, Argentina

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • JP

    JP

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Denis Blais, Canada

    Denis Blais, Canada

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Mark Miller, UK

    Mark Miller, UK

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • David Hall, USA

    David Hall, USA

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • David Bishop, UK

    David Bishop, UK

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Frank Taylor, USA

    Frank Taylor, USA

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • John Russo, USA

    John Russo, USA
    final3878

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Elkin Ramiro Gaviria Muñoz, Colombia

    Elkin Ramiro Gaviria Muñoz, Colombia

  • Glen Elison, USA

    Glen Elison, USA

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Rob Tison, USA

    Rob Tison, USA

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Lombana, Spain

    Lombana, Spain

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login